FDA OKs Sequent Medical trial for Web aneurysm device

Sequent Medical wins an FDA nod for an investigational device exemption trial of its Web aneurysm embolization device.

Sequent Medical armed itself last April with $20 million in venture cash earmarked for a U.S. IDE trial involving its Web aneurysm embolization device. Ten months later, it has the regulatory O.K. to proceed with the study.

Food & Drug Administration (FDA), Sequent Medical

News Well, Clinical Trials, Investigational Device Exemption (IDE), Neurovascular repair

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1EmYZEC